OptimizeRx released a corporate presentation outlining its Dynamic Audience Activation Platform (DAAP) and its use in predictive, privacy-focused marketing across healthcare professional and patient channels. The presentation said DAAP deals typically range between about USD 0.5 million and USD 1.5 million. OptimizeRx reported a stock price of USD 5.93 and a market capitalization of about USD 111.3 million. The presentation listed cash and cash equivalents of USD 23.4 million and total debt of USD 25.7 million. OptimizeRx also reported net revenue retention of 116% and revenue per average full-time employee of USD 839,000.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief on March 17, 2026, and is solely responsible for the information contained therein.
Comments